Evidence map›Paper›PMID 25979417›Full record

ArticleUltrasound in medicine & biology2015

Acoustic Cavitation-Mediated Delivery of Small Interfering Ribonucleic Acids with Phase-Shift Nano-Emulsions.

Mark T Burgess, Tyrone M Porter

Abstract read
In one paragraph

Article in Ultrasound in medicine & biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Delayed Echo Enhancement Imaging to Quantify Myocardial Infarct Size.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Acoustic vaporization threshold of lipid-coated perfluoropentane droplets.The Journal of the Acoustical Society of America · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Mark T BurgessDepartment of Mechanical Engineering and Center for Nanoscience and Nanobiotechnology, Boston University, Boston, Massachusetts, USA. Electronic address: marktb@bu.edu.
Tyrone M PorterDepartment of Mechanical Engineering and Center for Nanoscience and Nanobiotechnology, Boston University, Boston, Massachusetts, USA; Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA.
Boston University · US

Funding

Boston University Clinical and Translational Science Institute - U ProgramU54TR001012 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CENTER, DAVID M. · 2014 to 2014
$3.9M
Boston University Cross-Disciplinary Training in Nanotechnology for CancerR25CA153955 · NCI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI FALLER, DOUGLAS V, GOLDBERG, BENNETT B · 2010 to 2014
$2.1M
Neutral pressure-sensitive nanoemulsion for localized siRNA deliveryR03EB015089 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI PORTER, TYRONE · 2012 to 2013
$159k
NCATS NIH HHS U54TR001012NCI NIH HHS R25 CA153955NIBIB NIH HHS R03 EB015089
6 · The paper itself

Abstract

Localized, targeted delivery of small interfering ribonucleic acid (siRNA) has been the foremost hurdle in the use of siRNA for the treatment of various diseases. Major advances have been achieved in the synthesis of siRNA, which have led to greater target messenger RNA (mRNA) silencing and stability under physiologic conditions. Although numerous delivery strategies have shown promise, there are still limited options for targeted delivery and release of siRNA administered systemically. In this in vitro study, phase-shift nano-emulsions (PSNE) were explored as cavitation nuclei to facilitate free siRNA delivery to cancer cells via sonoporation. A cell suspension containing varying amounts of PSNE and siRNA was exposed to 5-MHz pulsed ultrasound at fixed settings (6.2-MPa peak negative pressure, 5-cycle pulses, 250-Hz pulse repetition frequency (PRF) and total exposure duration of 100 s). Inertial cavitation emissions were detected throughout the exposure using a passive cavitation detector. Successful siRNA delivery was achieved (i.e., >50% cell uptake) with high (>80%) viability. The percentage of cells with siRNA uptake was correlated with the amount of inertial cavitation activity generated from vaporized PSNE. The siRNA remained functional after delivery, significantly reducing expression of green fluorescent protein in a stably transfected cell line. These results indicate that vaporized PSNE can facilitate siRNA entry into the cytosol of a majority of sonicated cells and may provide a non-endosomal route for siRNA delivery.

Indexed as

Cell Line, TumorDelayed-Action PreparationsElectroporationEmulsionsHumansNanocapsulesNeoplasms, ExperimentalRNA, Small InterferingSonicationSoundDelayed-Action PreparationsEmulsionsNanocapsulesRNA, Small InterferingAcoustic cavitationAcoustic droplet vaporizationMicrobubblesNanomedicinePhase-shift nano-emulsionsSmall interfering RNASonoporationUltrasound

Identifiers

PMID25979417
PMCPMC4466208
OpenAlexW1605818293

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.